查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1744685

2032 年轉印膜市場預測：按產品類型、轉印方法、孔徑、應用、最終用戶和地區進行的全球分析

Transfer Membrane Market Forecasts to 2032 - Global Analysis By Product Type, Transfer Method, Pore Size, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球轉移膜市場預計在 2025 年達到 4.612 億美元，到 2032 年將達到 7.027 億美元，預測期內的複合年成長率為 6.2%。

轉膜是一種特殊的多孔材料，用於分子生物學和生物化學，將蛋白質和核酸等生物分子從凝膠轉移到撐體上進行分析。它們通常由硝酸纖維素或聚二氟亞乙烯(PVDF) 製成，可在西方印漬術和南方印跡等技術中確保目標分子的有效結合和保留。它們對生物分子的高親和性使其能夠在研究和診斷應用中實現精確的檢測、定量和表徵。

根據歐盟委員會2022年12月更新的工業研發投資預測，預計美國2022年在研發上的支出將超過6,790億美元。預計中國2022年在研發上的支出約為5,511億美元。

增加生命科學研究資金

各國政府和私人機構正大力投資生技和分子診斷，推動膜技術的進步。資金的激增支持了西方印漬術和核酸分析等創新應用的開發，從而提高了研究效率。此外，製藥和生物製藥公司正在擴大研發力度，進一步推動了對高性能轉膜的需求。因此，在持續的科學探索和技術改進的推動下，市場正在穩步成長。

膜選擇和客製化的複雜性

研究人員必須仔細評估膜的特性，例如孔徑、結合親和性以及與檢測方法的兼容性，以確保最佳性能。多種膜類型（例如硝酸纖維素、PVDF 和尼龍）的出現增加了複雜性，需要專業知識才能進行選擇。此外，客製化需要精確的製造步驟，這會增加生產成本和時間。這些因素對新進者構成了障礙，延遲了採購決策，並影響了市場擴張。

新型薄膜材料的開發

聚合物科學和奈米技術的進步使得我們能夠製造出靈敏度、耐久性和特異性更高的薄膜。研究人員正在探索生物工程膜，以提高蛋白質和核酸的轉移效率，以滿足不斷發展的實驗室需求。此外，永續性方面的擔憂也推動了對環保膜替代品的需求，促使製造商進行創新，這些創新有望重塑產業格局。

替代分析技術的快速進步

微射流、數位PCR和自動化成像系統等新技術正在減少對傳統膜基檢測方法的依賴。這些替代技術具有更高的準確性、更快的處理速度和更少的樣品消費量，因此對研究人員極具吸引力。隨著實驗室朝向更自動化和整合的工作流程邁進，對傳統轉膜的需求可能會減少。

COVID-19的影響：

新冠疫情對轉膜市場的影響良莠不齊，既影響了供應鏈，也影響了研究重點。製造和物流中斷導致供不應求，而對分子診斷和感染疾病研究的關注度增加則增加了膜需求。此外，疫情凸顯了高效生物分子轉膜的重要性，刺激了對高品質膜的投資。

尼龍轉膜市場預計將成為預測期內最大的市場

尼龍膜憑藉其優異的耐用性和強大的結合力，預計將在預測期內佔據最大的市場佔有率。尼龍膜能夠有效保留蛋白質，非常適合蛋白質西方印漬術等應用。其對多種檢測技術的適應性增強了效用。此外，其高效的生物分子轉移能力以及與先進染色方法的兼容性也是尼龍膜備受青睞的原因。

預計半乾電轉印領域在預測期內將以最高的複合年成長率成長。

半乾電轉印技術因其高通量和極低的緩衝液消耗，預計將在預測期內實現最高成長率。該技術因其能夠縮短轉印時間並確保分子的穩定保留而備受青睞。隨著對經濟高效且快速印跡解決方案的需求日益成長，實驗室正在轉向半乾法以簡化工作流程。

比最大的地區

在預測期內，北美預計將佔據最大的市場佔有率，推動了對高品質膜的持續需求。

複合年成長率最高的地區：

預計亞太地區將在預測期內呈現最高的複合年成長率。這得歸功於醫療保健投資的增加以及分子​​分析技術的日益普及。中國和印度等國家正大力提升其科學研究能力，從而推動了對轉膜的需求成長。人們對先進診斷工具的認知不斷提高，以及政府旨在加強生命科學基礎設施的舉措，也推動了市場的快速成長。

免費客製化服務：

訂閱此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司簡介
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 地理細分
    • 根據客戶興趣對主要國家市場進行估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 研究範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 限制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

第5章全球轉印膜市場（依產品類型）

  • 硝酸纖維素轉移膜
  • 聚二氟亞乙烯（PVDF）轉印膜
  • 尼龍轉移膜
  • 其他產品類型

6. 全球轉印膜市場（按轉印方式）

  • 濕式或槽式電轉印
  • 半乾式電轉
  • 乾電轉

7. 全球膜運輸市場（依孔徑）

  • 小於0.2微米
  • 0.2～0.45um
  • 0.45um以上

第8章全球轉印膜市場（按應用）

  • 西方印漬術
  • 南方印跡法
  • 北方印跡法
  • 蛋白質序列分析與胺基酸分析
  • 點/槽印跡法
  • 免疫印跡
  • 其他用途

第9章全球轉印膜市場（依最終用戶）

  • 學術研究所
  • 製藥和生物技術公司
  • 診斷實驗室
  • 合約開發和製造組織（CDMO）
  • 合約研究組織（CRO）
  • 其他最終用戶

第 10 章全球轉印膜市場（按區域）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Abcam
  • Advansta
  • ATTO Corporation
  • Azure Biosystems
  • Bio-Rad Laboratories
  • Carl Roth
  • Cytiva
  • GE Healthcare
  • Merck
  • Neogen Corporation
  • Pall Corporation
  • PerkinElmer
  • Roche Diagnostics
  • Santa Cruz Biotechnology Inc.
  • Sartorius AG
  • Thermo Fisher Scientific
  • MilliporeSigma
Product Code: SMRC29733

According to Stratistics MRC, the Global Transfer Membrane Market is accounted for $461.2 million in 2025 and is expected to reach $702.7 million by 2032 growing at a CAGR of 6.2% during the forecast period. Transfer membrane is a specialized porous material used in molecular biology and biochemistry to facilitate the transfer of biomolecules, such as proteins or nucleic acids, from a gel onto a solid support for analysis. Typically composed of nitrocellulose or polyvinylidene fluoride (PVDF), it ensures efficient binding and retention of target molecules during techniques like Western blotting or Southern blotting. Its high affinity for biomolecules enables precise detection, quantification, and characterization in research and diagnostic applications

According to the European Commission Industrial R&D Investment prediction, data updated in December 2022, the United States planned to spend more than USD 679 billion on research and development in 2022. It was anticipated that China would spend roughly USD 551.1 billion on R&D in 2022.

Market Dynamics:

Driver:

Increasing funding for life sciences research

Governments and private institutions are investing heavily in biotechnology and molecular diagnostics, leading to advancements in membrane technologies. This surge in funding supports the development of innovative applications such as Western blotting and nucleic acid analysis, enhancing research efficiency. Additionally, pharmaceutical and biopharmaceutical companies are expanding their R&D efforts, further boosting demand for high-performance transfer membranes. As a result, the market is witnessing steady growth, fueled by continuous scientific exploration and technological improvements.

Restraint:

Complexity of membrane selection and customization

Researchers must carefully evaluate membrane properties, including pore size, binding affinity, and compatibility with detection methods, to ensure optimal performance. The availability of multiple membrane types, such as nitrocellulose, PVDF, and nylon, adds to the complexity, requiring specialized knowledge for selection. Additionally, customization demands precise manufacturing processes, increasing production costs and time. These factors create barriers for new entrants and slow down procurement decisions, impacting market expansion.

Opportunity:

Development of novel membrane materials

Advances in polymer science and nanotechnology are enabling the creation of membranes with enhanced sensitivity, durability, and specificity. Researchers are exploring bioengineered membranes that improve protein and nucleic acid transfer efficiency, catering to evolving laboratory needs. Additionally, sustainability concerns are driving the demand for eco-friendly membrane alternatives, encouraging manufacturers to innovate expected to reshape the industry landscape.

Threat:

Rapid advancements in alternative analytical techniques

Emerging technologies such as microfluidics, digital PCR, and automated imaging systems are reducing reliance on traditional membrane-based assays. These alternatives offer higher precision, faster processing times, and reduced sample consumption, making them attractive to researchers. As laboratories transition to more automated and integrated workflows, the demand for conventional transfer membranes may decline.

Covid-19 Impact:

The COVID-19 pandemic had a mixed impact on the transfer membrane market, influencing both supply chains and research priorities. While disruptions in manufacturing and logistics led to temporary shortages, the heightened focus on molecular diagnostics and infectious disease research increased demand for membranes. Additionally, the pandemic underscored the importance of efficient biomolecule transfer, prompting investments in high-quality membranes.

The nylon transfer membranes segment is expected to be the largest during the forecast period

The nylon transfer membranes segment is expected to account for the largest market share during the forecast period due to its exceptional durability and strong binding capacity. Nylon membranes effectively retain proteins, making them highly suitable for applications such as Western blotting. Their adaptability across multiple detection techniques enhances their utility in research settings. Additionally, their efficiency in biomolecule transfer and compatibility with advanced staining methods contribute to their growing preference.

The semi-dry electrotransfer segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the semi-dry electrotransfer segment is predicted to witness the highest growth rate driven by its rapid processing capabilities and minimal buffer consumption. This technique is favored for its ability to accelerate transfer time while ensuring consistent molecular retention. With increasing demand for cost-effective and high-speed blotting solutions, laboratories are shifting toward semi-dry methods to streamline workflows.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its well-established biotechnology infrastructure and robust investments in life sciences research. The presence of leading pharmaceutical companies and advanced research institutions fosters continual innovation in transfer membrane applications. Additionally, strong government funding for molecular diagnostics and proteomics research reinforces the region's market leadership, driving sustained demand for high-quality membranes.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR supported by rising healthcare investments and growing adoption of molecular analysis techniques. Countries like China and India are significantly expanding their research capabilities, fostering greater demand for transfer membranes. Increasing awareness of advanced diagnostic tools and government initiatives aimed at strengthening life sciences infrastructure are contributing to rapid market growth

Key players in the market

Some of the key players in Transfer Membrane Market include Abcam, Advansta, ATTO Corporation, Azure Biosystems, Bio-Rad Laboratories, Carl Roth, Cytiva, GE Healthcare, Merck, Neogen Corporation, Pall Corporation, PerkinElmer, Roche Diagnostics, Santa Cruz Biotechnology Inc., Sartorius AG, Thermo Fisher Scientific and MilliporeSigma.

Key Developments:

In May 2025, Roche Diagnostics announced a strategic collaboration with Broad Clinical Labs to develop applications using Roche's SBX sequencing technology. The partnership aims to accelerate the adoption of cutting-edge sequencing solutions in clinical genomics.

In April 2025, Merck entered into a definitive agreement to acquire SpringWorks Therapeutics, a U.S. biopharmaceutical company. The acquisition aims to accelerate Merck's growth in the healthcare sector.

In March 2025, GE Healthcare announced the U.S. launch of Flyrcado, a unit dose PET myocardial perfusion imaging agent. Flyrcado aims to enhance cardiac imaging by providing improved diagnostic accuracy.

Product Types Covered:

  • Nitrocellulose Transfer Membranes
  • Polyvinylidene Fluoride (PVDF) Transfer Membranes
  • Nylon Transfer Membranes
  • Other Product Types

Transfer Methods Covered:

  • Wet or Tank Electrotransfer
  • Semi-Dry Electrotransfer
  • Dry Electrotransfer

Pore Sizes Covered:

  • <0.2 µm
  • 0.2-0.45 µm
  • >0.45 µm

Applications Covered:

  • Western Blotting
  • Southern Blotting
  • Northern Blotting
  • Protein Sequencing & Amino Acid Analysis
  • Dot/Slot Blotting
  • Immunoblotting
  • Other Applications

End Users Covered:

  • Academic & Research Institutions
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Contract Research Organizations (CROs)
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Transfer Membrane Market, By Product Type

  • 5.1 Introduction
  • 5.2 Nitrocellulose Transfer Membranes
  • 5.3 Polyvinylidene Fluoride (PVDF) Transfer Membranes
  • 5.4 Nylon Transfer Membranes
  • 5.5 Other Product Types

6 Global Transfer Membrane Market, By Transfer Method

  • 6.1 Introduction
  • 6.2 Wet or Tank Electrotransfer
  • 6.3 Semi-Dry Electrotransfer
  • 6.4 Dry Electrotransfer

7 Global Transfer Membrane Market, By Pore Size

  • 7.1 Introduction
  • 7.2 <0.2 µm
  • 7.3 0.2-0.45 µm
  • 7.4 >0.45 µm

8 Global Transfer Membrane Market, By Application

  • 8.1 Introduction
  • 8.2 Western Blotting
  • 8.3 Southern Blotting
  • 8.4 Northern Blotting
  • 8.5 Protein Sequencing & Amino Acid Analysis
  • 8.6 Dot/Slot Blotting
  • 8.7 Immunoblotting
  • 8.8 Other Applications

9 Global Transfer Membrane Market, By End User

  • 9.1 Introduction
  • 9.2 Academic & Research Institutions
  • 9.3 Pharmaceutical & Biotechnology Companies
  • 9.4 Diagnostic Laboratories
  • 9.5 Contract Development & Manufacturing Organizations (CDMOs)
  • 9.6 Contract Research Organizations (CROs)
  • 9.7 Other End Users

10 Global Transfer Membrane Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abcam
  • 12.2 Advansta
  • 12.3 ATTO Corporation
  • 12.4 Azure Biosystems
  • 12.5 Bio-Rad Laboratories
  • 12.6 Carl Roth
  • 12.7 Cytiva
  • 12.8 GE Healthcare
  • 12.9 Merck
  • 12.10 Neogen Corporation
  • 12.11 Pall Corporation
  • 12.12 PerkinElmer
  • 12.13 Roche Diagnostics
  • 12.14 Santa Cruz Biotechnology Inc.
  • 12.15 Sartorius AG
  • 12.16 Thermo Fisher Scientific
  • 12.17 MilliporeSigma

List of Tables

  • Table 1 Global Transfer Membrane Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Transfer Membrane Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Transfer Membrane Market Outlook, By Nitrocellulose Transfer Membranes (2024-2032) ($MN)
  • Table 4 Global Transfer Membrane Market Outlook, By Polyvinylidene Fluoride (PVDF) Transfer Membranes (2024-2032) ($MN)
  • Table 5 Global Transfer Membrane Market Outlook, By Nylon Transfer Membranes (2024-2032) ($MN)
  • Table 6 Global Transfer Membrane Market Outlook, By Other Product Types (2024-2032) ($MN)
  • Table 7 Global Transfer Membrane Market Outlook, By Transfer Method (2024-2032) ($MN)
  • Table 8 Global Transfer Membrane Market Outlook, By Wet or Tank Electrotransfer (2024-2032) ($MN)
  • Table 9 Global Transfer Membrane Market Outlook, By Semi-Dry Electrotransfer (2024-2032) ($MN)
  • Table 10 Global Transfer Membrane Market Outlook, By Dry Electrotransfer (2024-2032) ($MN)
  • Table 11 Global Transfer Membrane Market Outlook, By Pore Size (2024-2032) ($MN)
  • Table 12 Global Transfer Membrane Market Outlook, By <0.2 µm (2024-2032) ($MN)
  • Table 13 Global Transfer Membrane Market Outlook, By 0.2-0.45 µm (2024-2032) ($MN)
  • Table 14 Global Transfer Membrane Market Outlook, By >0.45 µm (2024-2032) ($MN)
  • Table 15 Global Transfer Membrane Market Outlook, By Application (2024-2032) ($MN)
  • Table 16 Global Transfer Membrane Market Outlook, By Western Blotting (2024-2032) ($MN)
  • Table 17 Global Transfer Membrane Market Outlook, By Southern Blotting (2024-2032) ($MN)
  • Table 18 Global Transfer Membrane Market Outlook, By Northern Blotting (2024-2032) ($MN)
  • Table 19 Global Transfer Membrane Market Outlook, By Protein Sequencing & Amino Acid Analysis (2024-2032) ($MN)
  • Table 20 Global Transfer Membrane Market Outlook, By Dot/Slot Blotting (2024-2032) ($MN)
  • Table 21 Global Transfer Membrane Market Outlook, By Immunoblotting (2024-2032) ($MN)
  • Table 22 Global Transfer Membrane Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 23 Global Transfer Membrane Market Outlook, By End User (2024-2032) ($MN)
  • Table 24 Global Transfer Membrane Market Outlook, By Academic & Research Institutions (2024-2032) ($MN)
  • Table 25 Global Transfer Membrane Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
  • Table 26 Global Transfer Membrane Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 27 Global Transfer Membrane Market Outlook, By Contract Development & Manufacturing Organizations (CDMOs) (2024-2032) ($MN)
  • Table 28 Global Transfer Membrane Market Outlook, By Contract Research Organizations (CROs) (2024-2032) ($MN)
  • Table 29 Global Transfer Membrane Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.